Navigation Links
Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
Date:10/31/2007

ch as statements about prospective earnings, revenue and earnings growth, are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements, including the statements contained herein regarding anticipated trends in the Company's business, are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, competitive factors and industry consolidation, outsourcing trends in the pharmaceutical and biotechnology industries, the Company's ability to manage growth and to continue to attract and retain qualified personnel, the Company's ability to complete additional acquisitions and to integrate newly acquired businesses, the Company's ability to penetrate new markets, the fixed price nature of contracts and cost overruns, the loss, cancellation or delay of contracts or amendments thereto, the ability to maintain existing customer relationships or enter into new ones, the Company's sales cycle, the effects of exchange rate fluctuations, risks related to non-U.S. operations and other factors described in the Company's filings with the Securities and Exchange Commission, including Quarterly Reports on Form 10-Q and the Annual Report on Form 10-K. No assurance can be given that the Company will be able to realize the net service revenues included in backlog and verbal awards. Kendle believes that its aggregate backlog and verbal awards are not necessarily a meaningful indicator of future results. All information in this release is current as of Oct. 31, 2007. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.

Kendle International Inc.


'/>"/>

SOURCE Kendle
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Woman Delivers Identical Quadruplets
2. No Carrier Necessary: This Drug Delivers Itself
3. Government Delivers On Emergency Medical Training For Rural Doctors
4. Fat Screen Delivers Plant-derived Chemical With Antidiabetic Effects
5. Cuban Healthcare Delivers, Experts Say
6. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
7. Record growth of Soya-based dairy alternatives in Europe
8. Gujarat Records Fall In AIDS Cases
9. Record Number of Countries Contributed to UNFPA in 2005
10. Indonesia Records Another Bird Flu Death
11. British Columbia Has The Best Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10MDS Inc Completes Divestiture of MDS Pharma Services Phase II IV Operations 50506 1MDS Inc Completes Divestiture of MDS Pharma Services Phase II IV Operations 50506 2Align Technology to Announce Second Quarter Fiscal 2009 Results on July 23 2009 50501 1Align Technology to Announce Second Quarter Fiscal 2009 Results on July 23 2009 50501 2Cancer survivors at greater risk of birth complications 3B special monitoring needed 50498 1Cancer survivors at greater risk of birth complications 3B special monitoring needed 50498 2